Brazil develops unprecedented research of new AIDS vaccine
In the first phase of the work developed by the Federal University of Pernambuco, 18 volunteers who are HIV carriers were submitted to three doses of the medication. Just one day after immunization, they presented on average 80% reduction of viral load.
By Mark Ament
